Related Experiment Videos
Vasculitis from the pediatric perspective
1The Institute of Child Health, 30 Guildford Street, London WC1N 1EH, United Kingdom.
Insights
This review covers childhood vasculitis, including common and rare types. While treatments have improved outcomes, significant illness and death still occur in pediatric vasculitis cases.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Internal Medicine
Background:
- Vasculitic illnesses encompass a range of disorders affecting children.
- Common pediatric vasculitides include Henoch-Schönlein purpura, Kawasaki disease, and Takayasu disease.
- Rare vasculitic disorders also impact the pediatric population.
Purpose of the Study:
- To review the spectrum of vasculitic illnesses in children.
- To highlight the overlap between different vasculitic syndromes in this age group.
- To discuss the current prognosis and challenges in childhood vasculitis.
Main Methods:
- Literature review of pediatric vasculitis.
- Analysis of common and rare vasculitic conditions in children.
- Discussion of diagnostic and therapeutic considerations.
Main Results:
- Significant overlap exists between various childhood vasculitic syndromes.
- Modern therapies have improved prognosis for many pediatric vasculitides.
- Despite advances, considerable morbidity and mortality persist.
Conclusions:
- Further understanding of immunopathogenesis is crucial for improving classification and treatment.
- Enhanced knowledge will benefit both pediatric and adult vasculitis management.
- Continued research is needed to reduce the impact of vasculitis in children.
Abstract:
This article reviews the spectrum of vasculitic illness affecting children. Apart from the relatively common vasculitides (Henoch-Schönlein purpura, Kawasaki disease, and in worldwide terms Takayasu disease) there are a number of important but comparatively rare disorders affecting children. As in adults, there is a considerable degree of overlap between the various vasculitic syndromes in childhood. With modern therapeutic agents, the prognosis for many of the childhood vasculitides has improved; however, in spite of this, there remains a not inconsequential morbidity and mortality. It is anticipated that as our knowledge of the immunopathogenesis of this group of disorders expands, classification and treatment of vasculitis in both children and adults will improve.